UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...

United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...

Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the ...

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...

The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ ...

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their ...

The U.S. Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants ...

Kingswood Wealth Advisors LLC bought a new position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) during ...

HB Wealth Management LLC bought a new stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The ...

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB), a commercial-stage biopharmaceutical company with a "GOOD" InvestingPro Financial ...